We are live on ! Find out more
CORZ

Core Scientific, Inc. Common Stock

Delisted

CORZ was delisted on the 30th of December, 2022.

141 hedge funds and large institutions have $105M invested in Core Scientific, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 68 funds opening new positions, 44 increasing their positions, 11 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

990% more call options, than puts

Call options by funds: $15.1M | Put options by funds: $1.38M

300% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 11

278% more first-time investments, than exits

New positions opened: 68 | Existing positions closed: 18

55% more funds holding

Funds holding: 91141 (+50)

50% less capital invested

Capital invested by funds: $210M → $105M (-$105M)

Holders
141
Holders Change
+50
Holders Change %
+54.95%
% of All Funds
2.37%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
68
Increased
44
Reduced
11
Closed
18
Calls
$15.1M
Puts
$1.38M
Net Calls
+$13.7M
Net Calls Change
-$12.1M

CORZ Hedge Fund Activity: Q2 2022 in Review

141 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Core Scientific, Inc. Common Stock (CORZ) for Q2 2022, worth a combined $105M — down 50% from $210M a quarter earlier.

Buyers outnumbered sellers: 68 funds opened new CORZ positions and 18 closed out — a net gain of 50 holders — while 44 added to existing stakes and 11 trimmed.

The largest buyer was BlackRock, adding an estimated $51.8M. The largest seller was Kensico Capital Management, exiting entirely with an estimated $7M sold.

  • 141 institutional investors held Core Scientific, Inc. Common Stock (CORZ) as of Q2 2022, up from 91 in Q1 2022.
  • Funds reported $105M of Core Scientific, Inc. Common Stock stock for Q2 2022, down 50% quarter-over-quarter.
  • 68 funds opened new Core Scientific, Inc. Common Stock positions in Q2 2022 and 18 closed out, a net change of +50 holders.
  • The largest Core Scientific, Inc. Common Stock buyer in Q2 2022 was BlackRock, an estimated $51.8M added.
  • The largest Core Scientific, Inc. Common Stock seller in Q2 2022 was Kensico Capital Management, an estimated $7M sold.

Based on aggregated 13F filings for Q2 2022.